199 related articles for article (PubMed ID: 25453753)
21. Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process.
Jorissen RN; Treutlein HR; Epa VC; Burgess AW
J Biomol Struct Dyn; 2002 Jun; 19(6):961-72. PubMed ID: 12023799
[TBL] [Abstract][Full Text] [Related]
22. Computational modeling reveals molecular details of epidermal growth factor binding.
Mayawala K; Vlachos DG; Edwards JS
BMC Cell Biol; 2005 Nov; 6():41. PubMed ID: 16318625
[TBL] [Abstract][Full Text] [Related]
23. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.
Ge G; Wu J; Wang Y; Lin Q
Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160
[TBL] [Abstract][Full Text] [Related]
24. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
Tao RH; Maruyama IN
J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
[TBL] [Abstract][Full Text] [Related]
25. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
[TBL] [Abstract][Full Text] [Related]
26. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
[TBL] [Abstract][Full Text] [Related]
27. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
[TBL] [Abstract][Full Text] [Related]
28. Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor.
Whitson KB; Whitson SR; Red-Brewer ML; McCoy AJ; Vitali AA; Walker F; Johns TG; Beth AH; Staros JV
Biochemistry; 2005 Nov; 44(45):14920-31. PubMed ID: 16274239
[TBL] [Abstract][Full Text] [Related]
29. EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.
Freed DM; Bessman NJ; Kiyatkin A; Salazar-Cavazos E; Byrne PO; Moore JO; Valley CC; Ferguson KM; Leahy DJ; Lidke DS; Lemmon MA
Cell; 2017 Oct; 171(3):683-695.e18. PubMed ID: 28988771
[TBL] [Abstract][Full Text] [Related]
30. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
31. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
[TBL] [Abstract][Full Text] [Related]
32. Critical effects on binding of epidermal growth factor produced by amino acid substitutions.
Mehrabi M; Khodarahmi R; Shahlaei M
J Biomol Struct Dyn; 2017 Apr; 35(5):1085-1101. PubMed ID: 27212100
[TBL] [Abstract][Full Text] [Related]
33. Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme.
Liu KJ; Chen CT; Hu WS; Hung YM; Hsu CY; Chuang BF; Juang SH
Int J Oncol; 2004 Mar; 24(3):581-90. PubMed ID: 14767543
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias.
Hu C; Leche CA; Kiyatkin A; Yu Z; Stayrook SE; Ferguson KM; Lemmon MA
Nature; 2022 Feb; 602(7897):518-522. PubMed ID: 35140400
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic Insights into R776H Mediated Activation of Epidermal Growth Factor Receptor Kinase.
Ruan Z; Kannan N
Biochemistry; 2015 Jul; 54(27):4216-25. PubMed ID: 26101090
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
Alvarado D; Klein DE; Lemmon MA
Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758
[TBL] [Abstract][Full Text] [Related]
37. Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".
Purba ER; Saita EI; Maruyama IN
Cells; 2017 Jun; 6(2):. PubMed ID: 28574446
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis for multimerization in the activation of the epidermal growth factor receptor.
Huang Y; Bharill S; Karandur D; Peterson SM; Marita M; Shi X; Kaliszewski MJ; Smith AW; Isacoff EY; Kuriyan J
Elife; 2016 Mar; 5():. PubMed ID: 27017828
[TBL] [Abstract][Full Text] [Related]
39. The EGFR family: not so prototypical receptor tyrosine kinases.
Lemmon MA; Schlessinger J; Ferguson KM
Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a020768. PubMed ID: 24691965
[TBL] [Abstract][Full Text] [Related]
40. The Epidermal Growth Factor Receptor Forms Location-Dependent Complexes in Resting Cells.
Yavas S; Macháň R; Wohland T
Biophys J; 2016 Nov; 111(10):2241-2254. PubMed ID: 27851946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
